Health Sciences Group Company Update

INDIAN HARBOR BEACH, FL--(Marketwire - December 14, 2009) - Health Sciences Group, Inc. (PINKSHEETS: HESG) would like to address the following concerns and updates to the current and future shareholders:

We would like to address and clarify a few questions and updates regarding recent and future activities of the Company.

1. The Company is making application to Pink Sheets, to apply for its disclosure and news service. Once approved and cleared through Pink Sheets compliance, along with an attorney letter in respect to such documents, the company will be disclosing all issues pertaining to the business of Health Sciences Group, including up to date financials and ISSUED, OUTSTANDING and AUTHORIZED shares. Upon approval the Company will be Pink Sheet Current tier. Hopefully this will take place in January 2010.

2. Scottrade and TD Ameritrade have stopped buy orders on our stock; you can sell but not buy stock through these two companies. We along with our corporate attorney have been diligently working on the situation in attempt to resolve such problem. Unfortunately, we have not had much progress with either company other than both companies telling us that the situation is temporary and it is being addressed. The majority of online penny stock investors use one or both of these firms. That is why we feel that our share volume has been down. We suggest using Zecco Trading, Scottsdale Capital Advisors, Worldtrade Financial, Fidelity, E-Trade etc.

3. Until late October HESG was just an online and magazine/newsletter company. It wasn't until late October that we announced the Company would be exploring opportunities with medical marijuana. Since our announcement our stock price has increased and we have made many large and small relationships within the medical marijuana industry.

4. The Company has no intentions of doing a reverse stock split.

5. The Company does have intentions of increasing our authorized shares for purposes of acquisitions, this number is yet to be decided.

6. Due to the situation with a drop in our stock price and the situation surrounding TD Ameritrade and Scottrade our acquisitions of two Montana medical marijuana facilities have been set aside until we resolve the stock trading issues. However there are now 14 states and Washington, D.C. which allow certain opportunities for the Company to establish a presence within the medical marijuana industry in each of the fifteen which we are investigating and exploring.

7. We encourage all investors and potential investors to contact our New Investor Relations Department at info@igohealthy.org with any questions. And we will be adding a company updates section to our website by next week.

8. We have in fact retired 2.0 billion restricted common shares. This does not affect the authorized share count.

9. Lastly, we are in a booming industry. Many ill people can benefit from medical marijuana and we feel it will be legal for medical purposes nationwide in times to come.

ABOUT HEALTH SCIENCES GROUP, INC.

Health Sciences Group, Inc. is a provider of health and wellness services to consumers, physicians and other healthcare professionals through its website, www.igohealthy.org, and health focused publications. The Health Sciences network consists of its public website, www.igohealthy.org, and iGoHealthy Magazine. The Company operates in three segments: Online Services, Publishing and Other Services. The Company is recently exploring options of corporate growth within the Legal Medical Marijuana Industry.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Health Sciences Group, Inc. to be materially different from the statements made herein.

Contact Information: By Staff CONTACT: Health Sciences Group, Inc. Investor Relations Health Sciences Group, Inc. Frank Godleski IR Representative Email Contact: